Sekisui Medical has appointed Robert Schruender to their Board of Directors in addition to current Sekisui Diagnostics group (SDG) CEO role, effective June 20th after the completion of the stockholder meeting.

Over the past several years, Bob has demonstrated his strong leadership as SDG COO and now will show his great capability more widely and globally, as a new board member.

Sekisui Medical strongly believes his participation is valuable and necessary to change the corporate culture, to enhance and accelerate the synergies between the two companies, and to transform the Sekisui Medical Group into a strong global organization.